Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun:245:233-237.
doi: 10.1016/j.jpeds.2022.03.032. Epub 2022 Mar 26.

Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis

Affiliations
Case Reports

Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis

Jenna Schauer et al. J Pediatr. 2022 Jun.

Abstract

We describe the evolution of cardiac magnetic resonance imaging findings in 16 patients, aged 12-17 years, with myopericarditis after the second dose of the Pfizer mRNA coronavirus disease 2019 vaccine. Although all patients showed rapid clinical improvement, many had persistent cardiac magnetic resonance imaging findings at 3- to 8-month follow-up.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of LGE in AHA myocardial segments. Shown is the number and percentage of patients with LGE in each segment. AHA, American Heart Association.
Figure 2
Figure 2
Cardiac MRI scans from 3 days after admission of a 16-year-old male patient who presented to the emergency department with chest pain and elevated troponin 3 days after receiving the Pfizer COVID-19 mRNA vaccine. Initial cardiac MRI. A and B, Subepicardial to midmyocardial LGE in inferior and inferolateral LV wall from base to apex (arrows). C, T2 hyperintensity in similar segments, consistent with edema. D-F, Follow-up cardiac MRI 4.4 months later. LGE is still persistent but decreased from 26% to 19.84% (arrows), and LVEF remained stable at 58%. There is improved T2 hyperintensity.

References

    1. Gargano J.W., Wallace M., Hadler S.C., Langley G., Su J.R., Oster M.E., et al. Morbidity and Mortality Weekly Report Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:977–982. doi: 10.15585/mmwr.mm7027e2externalicon. - DOI - PMC - PubMed
    1. Kohli U., Desai L., Chowdhury D., Harahsheh A.S., Yonts A.B., Ansong A., et al. mRNA coronavirus-19 vaccine–associated myopericarditis in adolescents: a survey study. J Pediatr. 2021;243:208–213.e3. doi: 10.1016/j.jpeds.2021.12.025. - DOI - PMC - PubMed
    1. Truong D.T., Dionne A., Muniz J.C., McHugh K.E., Portman M.A., Lambert L.M., et al. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. 2022;145:345–356. doi: 10.1161/circulationaha.121.056583. - DOI - PubMed
    1. Schauer J., Buddhe S., Colyer J., Sagiv E., Law Y., Mallenahalli Chikkabyrappa S., et al. Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. J Pediatr. 2021;238:317–320. doi: 10.1016/j.jpeds.2021.06.083. - DOI - PMC - PubMed
    1. Yang F., Wang J., Li W., Xu Y., Wan K., Zeng R., et al. The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis. Eur Radiol. 2020;30:2616–2626. doi: 10.1007/s00330-019-06643-5. - DOI - PubMed

Publication types